Publications – Rare Diseases

Hedgeman E, Ulrichsen SP, Carter S, Kreher NC, Malobisky KP, Braun MM, Fryzek J, Olsen MS. Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark. Int J Obes (Lond). 2017 Oct;41(10):1531-1538.

Mullins M, Jiang X, Bylsma LC, Fryzek JP, Reichert H, Chen EC, Kummar S, Rosenthal A. Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization. Blood Adv. 2017 May 19;1(13):839-848.

Mullins M, Jiang X, Bylsma LC, et al. Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and healthcare utilization. Blood Advances. 2017;1:839-848.

Beebe-Dimmer JL, Fryzek JP, Yee CL, Dalvi TB, Garabrant DH, Schwartz AG, Gadgeel S. Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol. 2016 Oct 26;8:743-750.

Liu B, Kerath SM, Sekeres MA, Fryzek JP, Sreekantaiah C, Mason CR, Kolitz J, Taioli E. Myelodysplastic syndromes spatial clusters in disease etiology and outcome. Leuk Lymphoma. 2015 Oct 5:1-8.

Nguyen-Nielsen M, Wang L, Pedersen L, Braae Olesen A, Hou K, Mackey H, McCusker M, Basset-Seguin N, Fryzek JP, Vyberg M. The incidence of metastatic basal cell carcinoma in Denmark 1997-2010. Eur J Dermatol. 2015 Sep-Oct;25(5):463-8

Cohen SS, Skovbo S, Vestergaard H, Kristensen T, Moller M, Bindslev-Jensen C, Fryzek JP, Broesby-Olsen S.  Epidemiology of Systemic Mastocytosis in Denmark. Br J Haematol. 2014 Aug;166(4):521-8.

Mehta J, Wang H, Fryzek JP, Iqbal SU, Mesa R. Health Resource Utilization and Cost Associated with Myeloproliferative neoplasms (MPN) in a Large United States Health Plan. Leuk Lymphoma. 2014 Jan 23.

Moulard O, Mehta J, Fryzek J, Olivares R, Iqbal U, Mesa RA. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol. 2013 Dec 24.

Nguyen-Nielsen M, Skovbo S, Svaneby D, Pedersen L, Fryzek J. The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995-2010. Eur J Med Genet. 2013 Feb 14.

Mitchell ME, Lowe K, Fryzek J. A multisource approach to improving epidemiologic estimates: application to global B-cell malignancies. ISRN Oncol. 2012;2012:129713. Epub 2012 Dec 31.

Deuson R, Danese M, Mathias SD, Schoonen M, Fryzek J. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim. J Med Econ. 2012;15(5):956-76.

Mutetwa B, Fryzek J, Du Y, Yong M, Sekeres MA, Taioli E. Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western Pennsylvania. Leuk Lymphoma. 2011 Feb;52(2):265-72.

De Roos AJ, Deeg HJ, Onstad L, Kopecky KJ, Bowles EJ, Yong M, Fryzek J, Davis S. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006. Am J Hematol. 2010 Oct;85(10):765-70.

Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, Fryzek J, Kaye JA. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol. 2010 Jun;149(6):855-64.

Jensen AO, Nørgaard M, Engebjerg MC, Farkas DK, Fryzek JP, Zhao S, Sørensen HT. Predictors for splenectomy among patients with primary chronic immune thrombocytopenia: a population-based cohort study from Denmark. Ann Hematol. 2011Feb;90(2):207-12.

Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K. The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004). Rare Tumors. 2009 Dec 28;1(2):e52.

Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, Fryzek J, Kaye JA. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009 Apr;145(2):235-44.

Sekeres MA, Schoonen WM, Kantarjian H, List A, Fryzek J, Paquette R, Maciejewski JP. Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst. 2008 Nov 5;100(21):1542-51.

Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 2007; 120 Suppl 12:40-61.

Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007; 120 Suppl 12:1-39.

Fryzek JP, Garabrant DH, Schenk M, Kinnard M, Greenson JK, Sarkar FH. The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations. Int J Gastrointest Cancer. 2006;37(4):139-45.

Chatla C, Jhala NC, Katkoori VR, Alexander DD, Meleth S, Grizzle WE, Manne U. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma. Cancer Biomark. 2006 Oct;56(7):485-93.